{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:13:05Z","timestamp":1794849185911,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma multiforme (GBM), the most common malignant brain tumor, has a short period of survival even with recent multimodality treatment. The neurotropic JC polyomavirus (JCPyV) infects glial cells and oligodendrocytes and causes fatal progressive multifocal leukoencephalopathy in patients with AIDS. In this study, a possible gene therapy strategy for GBM using JCPyV virus-like particles (VLPs) as a gene delivery vector was investigated. We found that JCPyV VLPs were able to deliver the GFP reporter gene into tumor cells (U87-MG) for expression. In an orthotopic xenograft model, nude mice implanted with U87 cells expressing the near-infrared fluorescent protein and then treated by intratumoral injection of JCPyV VLPs carrying the thymidine kinase suicide gene, combined with ganciclovir administration, exhibited significantly prolonged survival and less tumor fluorescence during the experiment compared with controls. Furthermore, JCPyV VLPs were able to protect and deliver a suicide gene to distal subcutaneously implanted U87 cells in nude mice via blood circulation and inhibit tumor growth. These findings show that metastatic brain tumors can be targeted by JCPyV VLPs carrying a therapeutic gene, thus demonstrating the potential of JCPyV VLPs to serve as a gene therapy vector for the far highly treatment-refractory GBM.<\/jats:p>","DOI":"10.1038\/s41598-018-19825-w","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T11:43:51Z","timestamp":1517226231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector"],"prefix":"10.1038","volume":"8","author":[{"given":"Chun-Nun","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mien-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Kuo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Huang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lain","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"19825_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/cncr.21990","volume":"107","author":"T Byers","year":"2006","unstructured":"Byers, T. et al. A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer 107, 396\u2013405, https:\/\/doi.org\/10.1002\/cncr.21990 (2006).","journal-title":"Cancer"},{"key":"19825_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987\u2013996, https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N Engl J Med"},{"key":"19825_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","volume":"107","author":"DR Johnson","year":"2012","unstructured":"Johnson, D. R. & O\u2019Neill, B. P. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 107, 359\u2013364, https:\/\/doi.org\/10.1007\/s11060-011-0749-4 (2012).","journal-title":"J Neurooncol"},{"key":"19825_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4065\/82.10.1271","volume":"82","author":"JC Buckner","year":"2007","unstructured":"Buckner, J. C. et al. Central nervous system tumors. Mayo Clin Proc 82, 1271\u20131286, https:\/\/doi.org\/10.4065\/82.10.1271 (2007).","journal-title":"Mayo Clin Proc"},{"key":"19825_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJM197202242860801","volume":"286","author":"LP Weiner","year":"1972","unstructured":"Weiner, L. P. et al. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 286, 385\u2013390, https:\/\/doi.org\/10.1056\/nejm197202242860801 (1972).","journal-title":"N Engl J Med"},{"key":"19825_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","volume":"1","author":"BL Padgett","year":"1971","unstructured":"Padgett, B. L., Walker, D. L., ZuRhein, G. M., Eckroade, R. J. & Dessel, B. H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257\u20131260 (1971).","journal-title":"Lancet"},{"key":"19825_CR7","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/JVI.72.6.4643-4649.1998","volume":"72","author":"CK Liu","year":"1998","unstructured":"Liu, C. K., Wei, G. & Atwood, W. J. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. Journal of virology 72, 4643\u20134649 (1998).","journal-title":"Journal of virology"},{"key":"19825_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1073\/pnas.67.1.37","volume":"67","author":"JV Osterman","year":"1970","unstructured":"Osterman, J. V., Waddell, A. & Aposhian, H. V. DNA and gene therapy: uncoating of polyoma pseudovirus in mouse embryo cells. Proc Natl Acad Sci USA 67, 37\u201340 (1970).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 1","key":"19825_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1099\/0022-1317-80-1-39","volume":"80","author":"WC Ou","year":"1999","unstructured":"Ou, W. C. et al. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J Gen Virol 80(Pt 1), 39\u201346 (1999).","journal-title":"J Gen Virol"},{"key":"19825_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/gt.2010.50","volume":"17","author":"LS Chen","year":"2010","unstructured":"Chen, L. S. et al. Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model. Gene Ther 17, 1033\u20131041, https:\/\/doi.org\/10.1038\/gt.2010.50 (2010).","journal-title":"Gene Ther"},{"key":"19825_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.084","author":"CY Fang","year":"2015","unstructured":"Fang, C. Y. et al. Inhibition of Human Bladder Cancer Growth by a Suicide Gene Delivered by JC Polyomavirus Virus-Like Particles in a Mouse Model. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2015.01.084 (2015).","journal-title":"J Urol"},{"key":"19825_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0389-0","volume":"13","author":"CN Chao","year":"2015","unstructured":"Chao, C. N. et al. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene. Journal of translational medicine 13, 29, https:\/\/doi.org\/10.1186\/s12967-015-0389-0 (2015).","journal-title":"Journal of translational medicine"},{"key":"19825_CR13","doi-asserted-by":"publisher","first-page":"e0157865","DOI":"10.1371\/journal.pone.0157865","volume":"11","author":"CN Chao","year":"2016","unstructured":"Chao, C. N. et al. Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like Particles. PLoS One 11, e0157865, https:\/\/doi.org\/10.1371\/journal.pone.0157865 (2016).","journal-title":"PLoS One"},{"issue":"Pt 6","key":"19825_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1099\/0022-1317-78-6-1435","volume":"78","author":"D Chang","year":"1997","unstructured":"Chang, D. et al. Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J Gen Virol 78(Pt 6), 1435\u20131439 (1997).","journal-title":"J Gen Virol"},{"key":"19825_CR15","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.73.5.4465-4469.1999","volume":"73","author":"C Goldmann","year":"1999","unstructured":"Goldmann, C. et al. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. Journal of virology 73, 4465\u20134469 (1999).","journal-title":"Journal of virology"},{"key":"19825_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0166-0934(02)00036-8","volume":"104","author":"AD Hale","year":"2002","unstructured":"Hale, A. D. et al. Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae. J Virol Methods 104, 93\u201398 (2002).","journal-title":"J Virol Methods"},{"key":"19825_CR17","first-page":"455","volume":"116","author":"K Nagashima","year":"1984","unstructured":"Nagashima, K. et al. Induction of brain tumors by a newly isolated JC virus (Tokyo-1 strain). Am J Pathol 116, 455\u2013463 (1984).","journal-title":"Am J Pathol"},{"key":"19825_CR18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.211583","volume":"201","author":"WT London","year":"1978","unstructured":"London, W. T. et al. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201, 1246\u20131249 (1978).","journal-title":"Science"},{"key":"19825_CR19","first-page":"4287","volume":"61","author":"L Del Valle","year":"2001","unstructured":"Del Valle, L. et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 61, 4287\u20134293 (2001).","journal-title":"Cancer Res"},{"key":"19825_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1212\/WNL.58.6.895","volume":"58","author":"L Del Valle","year":"2002","unstructured":"Del Valle, L. et al. Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme. Neurology 58, 895\u2013900 (2002).","journal-title":"Neurology"},{"key":"19825_CR21","first-page":"1367","volume":"33","author":"M Momiyama","year":"2013","unstructured":"Momiyama, M. et al. Dynamic subcellular imaging of cancer cell mitosis in the brain of live mice. Anticancer Res 33, 1367\u20131371 (2013).","journal-title":"Anticancer Res"},{"key":"19825_CR22","doi-asserted-by":"publisher","first-page":"265487","DOI":"10.1155\/2012\/265487","volume":"2012","author":"K Tanaka","year":"2012","unstructured":"Tanaka, K. et al. In vivo time-course imaging of tumor angiogenesis in colorectal liver metastases in the same living mice using two-photon laser scanning microscopy. J Oncol 2012, 265487, https:\/\/doi.org\/10.1155\/2012\/265487 (2012).","journal-title":"J Oncol"},{"key":"19825_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4161\/cc.26985","volume":"13","author":"AK Hock","year":"2014","unstructured":"Hock, A. K. et al. iRFP is a sensitive marker for cell number and tumor growth in high-throughput systems. Cell Cycle 13, 220\u2013226, https:\/\/doi.org\/10.4161\/cc.26985 (2014).","journal-title":"Cell Cycle"},{"key":"19825_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/viro.2002.1522","volume":"300","author":"BJ Chen","year":"2002","unstructured":"Chen, B. J. & Atwood, W. J. Construction of a novel JCV\/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 300, 282\u2013290 (2002).","journal-title":"Virology"},{"key":"19825_CR25","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1128\/JVI.02252-13","volume":"87","author":"B Assetta","year":"2013","unstructured":"Assetta, B. et al. 5-HT2 receptors facilitate JC polyomavirus entry. Journal of virology 87, 13490\u201313498, https:\/\/doi.org\/10.1128\/jvi.02252-13 (2013).","journal-title":"Journal of virology"},{"key":"19825_CR26","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1128\/JVI.02123-07","volume":"82","author":"AS Dugan","year":"2008","unstructured":"Dugan, A. S., Gasparovic, M. L. & Atwood, W. J. Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus). Journal of virology 82, 2560\u20132564, https:\/\/doi.org\/10.1128\/jvi.02123-07 (2008).","journal-title":"Journal of virology"},{"key":"19825_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick, G. F. et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306, 1380\u20131383, https:\/\/doi.org\/10.1126\/science.1103492 (2004).","journal-title":"Science"},{"key":"19825_CR28","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1128\/JVI.74.5.2288-2292.2000","volume":"74","author":"MT Pho","year":"2000","unstructured":"Pho, M. T., Ashok, A. & Atwood, W. J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. Journal of virology 74, 2288\u20132292 (2000).","journal-title":"Journal of virology"},{"key":"19825_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.chom.2010.09.004","volume":"8","author":"U Neu","year":"2010","unstructured":"Neu, U. et al. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8, 309\u2013319, https:\/\/doi.org\/10.1016\/j.chom.2010.09.004 (2010).","journal-title":"Cell Host Microbe"},{"key":"19825_CR30","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.ajpath.2015.04.003","volume":"185","author":"SA Haley","year":"2015","unstructured":"Haley, S. A. et al. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol 185, 2246\u20132258, https:\/\/doi.org\/10.1016\/j.ajpath.2015.04.003 (2015).","journal-title":"Am J Pathol"},{"key":"19825_CR31","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1128\/JVI.76.24.12992-13000.2002","volume":"76","author":"R Komagome","year":"2002","unstructured":"Komagome, R. et al. Oligosaccharides as receptors for JC virus. Journal of virology 76, 12992\u201313000 (2002).","journal-title":"Journal of virology"},{"key":"19825_CR32","doi-asserted-by":"publisher","first-page":"e1000368","DOI":"10.1371\/journal.pgen.1000368","volume":"5","author":"SR Sunyaev","year":"2009","unstructured":"Sunyaev, S. R., Lugovskoy, A., Simon, K. & Gorelik, L. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS genetics 5, e1000368, https:\/\/doi.org\/10.1371\/journal.pgen.1000368 (2009).","journal-title":"PLoS genetics"},{"key":"19825_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/infdis\/jir198","volume":"204","author":"L Gorelik","year":"2011","unstructured":"Gorelik, L. et al. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. The Journal of infectious diseases 204, 103\u2013114, https:\/\/doi.org\/10.1093\/infdis\/jir198 (2011).","journal-title":"The Journal of infectious diseases"},{"key":"19825_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.virusres.2013.09.030","volume":"178","author":"GV Gee","year":"2013","unstructured":"Gee, G. V., O\u2019Hara, B. A., Derdowski, A. & Atwood, W. J. Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV. Virus research 178, 281\u2013286, https:\/\/doi.org\/10.1016\/j.virusres.2013.09.030 (2013).","journal-title":"Virus research"},{"key":"19825_CR35","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1128\/JVI.00489-15","volume":"89","author":"LJ Stroh","year":"2015","unstructured":"Stroh, L. J. et al. The Greater Affinity of JC Polyomavirus Capsid foralpha2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity. Journal of virology 89, 6364\u20136375, https:\/\/doi.org\/10.1128\/jvi.00489-15 (2015).","journal-title":"Journal of virology"},{"key":"19825_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s004010050427","volume":"91","author":"Y Kaneko","year":"1996","unstructured":"Kaneko, Y. et al. The expression of Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol 91, 284\u2013292 (1996).","journal-title":"Acta Neuropathol"},{"key":"19825_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-8993(97)00241-2","volume":"755","author":"H Yamamoto","year":"1997","unstructured":"Yamamoto, H. et al. alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas. Brain Res 755, 175\u2013179 (1997).","journal-title":"Brain Res"},{"key":"19825_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-328X(96)00058-7","volume":"41","author":"A Merzak","year":"1996","unstructured":"Merzak, A., Koochekpour, S., Fillion, M. P., Fillion, G. & Pilkington, G. J. Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. Brain Res Mol Brain Res 41, 1\u20137 (1996).","journal-title":"Brain Res Mol Brain Res"},{"key":"19825_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/B:NEON.0000041874.02554.b3","volume":"69","author":"EA Chiocca","year":"2004","unstructured":"Chiocca, E. A., Broaddus, W. C., Gillies, G. T., Visted, T. & Lamfers, M. L. Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology. J Neurooncol 69, 101\u2013117 (2004).","journal-title":"J Neurooncol"},{"key":"19825_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/sj.cgt.7700355","volume":"8","author":"NG Rainov","year":"2001","unstructured":"Rainov, N. G. et al. Temozolomide enhances herpes simplex virus thymidine kinase\/ganciclovir therapy of malignant glioma. Cancer Gene Ther 8, 662\u2013668, https:\/\/doi.org\/10.1038\/sj.cgt.7700355 (2001).","journal-title":"Cancer Gene Ther"},{"key":"19825_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0360-3016(01)02754-7","volume":"52","author":"E Rosenberg","year":"2002","unstructured":"Rosenberg, E. et al. Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus. Int J Radiat Oncol Biol Phys 52, 831\u2013836 (2002).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"19825_CR42","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1089\/104303400750035726","volume":"11","author":"AM Sandmair","year":"2000","unstructured":"Sandmair, A. M. et al. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 11, 2197\u20132205, https:\/\/doi.org\/10.1089\/104303400750035726 (2000).","journal-title":"Hum Gene Ther"},{"key":"19825_CR43","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1200\/JCO.2003.21.13.2508","volume":"21","author":"FF Lang","year":"2003","unstructured":"Lang, F. F. et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 21, 2508\u20132518 (2003).","journal-title":"J Clin Oncol"},{"key":"19825_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1023\/B:NEON.0000003588.18644.9c","volume":"65","author":"MD Prados","year":"2003","unstructured":"Prados, M. D. et al. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I\/II multi-institutional trial. J Neurooncol 65, 269\u2013278 (2003).","journal-title":"J Neurooncol"},{"key":"19825_CR45","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","volume":"11","author":"NG Rainov","year":"2000","unstructured":"Rainov, N. G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11, 2389\u20132401, https:\/\/doi.org\/10.1089\/104303400750038499 (2000).","journal-title":"Hum Gene Ther"},{"key":"19825_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cancers3010461","volume":"3","author":"P Beauchesne","year":"2011","unstructured":"Beauchesne, P. Extra-neural metastases of malignant gliomas: myth or reality? Cancers (Basel) 3, 461\u2013477, https:\/\/doi.org\/10.3390\/cancers3010461 (2011).","journal-title":"Cancers (Basel)"},{"key":"19825_CR47","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2008.16.3543","volume":"26","author":"H Chen","year":"2008","unstructured":"Chen, H., Shah, A. S., Girgis, R. E. & Grossman, S. A. Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol 26, 3284\u20133285, https:\/\/doi.org\/10.1200\/jco.2008.16.3543 (2008).","journal-title":"J Clin Oncol"},{"key":"19825_CR48","doi-asserted-by":"publisher","first-page":"247ra101","DOI":"10.1126\/scitranslmed.3009095","volume":"6","author":"C Muller","year":"2014","unstructured":"Muller, C. et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6, 247ra101, https:\/\/doi.org\/10.1126\/scitranslmed.3009095 (2014).","journal-title":"Sci Transl Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19825-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:00:50Z","timestamp":1671588050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19825-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19825"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19825-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2213"}}